Trifluoroacetic acid → HCID 86757032, compound
Reaction equation
[C:1]([C:5]1[CH:10]=[CH:9][N:8]2[C:11]([CH:14]3[CH2:19][CH2:18][N:17]([CH2:20][C@@H:21]4[C@@H:25]([C:26]5[CH:31]=[CH:30][CH:29]=[C:28]([F:32])[CH:27]=5)[CH2:24][N:23]([C@@:33]([CH:47]5[CH2:50][CH2:49][CH2:48]5)([CH3:46])[C:34]([O:36]CC5C=CC(OC)=CC=5)=[O:35])[CH2:22]4)[CH2:16][CH2:15]3)=[CH:12][N:13]=[C:7]2[CH:6]=1)([CH3:4])([CH3:3])[CH3:2].C(O)(C(F)(F)F)=O.C1(OC)C=CC=CC=1>>[C:1]([C:5]1[CH:10]=[CH:9][N:8]2[C:11]([CH:14]3[CH2:15][CH2:16][N:17]([CH2:20][C@@H:21]4[C@@H:25]([C:26]5[CH:31]=[CH:30][CH:29]=[C:28]([F:32])[CH:27]=5)[CH2:24][N:23]([C@@:33]([CH:47]5[CH2:48][CH2:49][CH2:50]5)([CH3:46])[C:34]([OH:36])=[O:35])[CH2:22]4)[CH2:18][CH2:19]3)=[CH:12][N:13]=[C:7]2[CH:6]=1)([CH3:2])([CH3:3])[CH3:4]Participants
4
Procedure
The title compound was prepared from 40 mg of α-(R)-(3-(S)-((4-(7-t-butyl-imidazo[1,2-a]pyridin-3-yl)-piperidine-1-yl)methyl)-4-(S)-(3-fluorophenyl) pyrrolidin-1-yl)-cyclobutylpropanoic acid, 4-methoxy-benzyl ester (from Step D), 2 mL of TFA and 0.4 mL of anisole, using a procedure analogous to that described in Example 235, Step D to provide 30 mg of the title compound as a foamy solid. ESI-MS 561 (M+H); HPLC A 1.92 min.
Sources & evidence
- ORD record
- ord-164a80a72fff4f35b2dce622cb14846a
- Source dataset
- uspto-grants-2001_06
- Patent number
- US06248755B1
Reaction notes
Loading…